文献速递冠心病心律失常心力衰竭与心肌病

心肌梗死后低射血分数医保患者心功能再评估与ICD使用情况

Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction.
PubMed 文献 · Circulation · 2016-11-16

该研究基于ACTION Registry-GWTG数据,纳入10 289例≥65岁、心梗入院时EF≤35%的医保患者,分析出院后EF再评估率及其与1年ICD植入的关系。结果显示66.8%的患者在1年内完成EF再评估,再评估与更高的ICD植入可能性相关,但即使再评估后1年ICD植入率仍仅11%。

要点

  • 心梗后EF≤35%的老年医保患者中,66.8%在1年内完成EF再评估。
  • 再评估患者1年ICD植入率仅11%,总体植入率很低。
  • 血运重建患者再评估率更高(76.9% vs 53.7%),再评估时间更短。

核心结论

  • 美国实践中,心梗后初始低EF患者常进行EF再评估,再评估与1年ICD植入可能性增加相关,但1年ICD植入率仍很低,无论血运重建状态如何。

研究设计与样本

  • 回顾性队列研究,纳入ACTION Registry-GWTG中2007年1月至2010年9月10 289例≥65岁、心梗入院时EF≤35%的医保患者。

主要发现

  • 66.8%(95%CI 65.9-67.8)的患者在出院后1年内完成EF再评估。
  • 血运重建患者再评估率76.9%(95%CI 75.8-78.0),非血运重建患者53.7%(95%CI 52.2-55.2),P<0.001。
  • 血运重建患者再评估中位时间67天,非血运重建患者84天,P<0.001。
  • 再评估患者中仅11%在1年内接受ICD植入。
  • 再评估与ICD植入相关:血运重建患者未调整12.1% vs 2.4%(P<0.001),调整HR 10.6(95%CI 7.7-14.8);非血运重建患者未调整10.0% vs 1.7%(P<0.001),调整HR 6.1(95%CI 4.1-9.2)。

临床怎么用

  • 对心梗后EF≤35%的患者应关注出院后EF再评估,但其与ICD植入率低的关系提示需进一步优化ICD候选者筛选与转诊流程。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Guidelines recommend that patients with low ejection fraction (EF) after myocardial infarction (MI) have their EF reassessed 40 days after MI for implantable cardioverter-defibrillator (ICD) candidacy. This study examines rates of EF reassessment and their association with 1-year ICD implantation in post-MI patients with low EF. METHODS: We examined rates of postdischarge EF reassessment and ICD implantation among 10 289 Medicare-insured patients ≥65 years of age with an EF≤35% during the index MI admission from January 2007 through September 2010 in ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines). Multivariable Cox models tested the association between time-dependent EF reassessment and 1-year ICD implantation, stratified by revascularization status during the index MI admission. RESULTS: Among patients with EF ≤35% during the index MI admission, 66.8% (95% confidence interval [CI], 65.9-67.8) had EF reassessment within the next year. Revascularized patients were more likely to have EF reassessment (76.9% [95% CI, 75.8-78.0)] versus 53.7% [95% CI, 52.2-55.2]; P<0.001) and had shorter times to EF reassessment (median, 67 versus 84 days; P<0.001) than nonrevascularized patients. Among patients with EF reassessment, only 11% received an ICD within 1 year. Reassessment of EF was associated with a higher likelihood of ICD implantation for both revascularized (unadjusted, 12.1% versus 2.4%, P<0.001; adjusted hazard ratio, 10.6, 95% CI, 7.7-14.8) and nonrevascularized (unadjusted, 10.0% versus 1.7%, P<0.001; adjusted hazard ratio, 6.1, 95% CI, 4.1-9.2) patients. CONCLUSIONS: In US practice, EF reassessments are commonly performed among patients with MI with an initially reduced EF. Although 1-year EF reassessment is associated with increased likelihood of ICD implantation, 1-year ICD implantation rates remain very low even among patients with EF reassessment, regardless of revascularization status.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Pokorney SD, Miller AL, Chen AY, et al. Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction. Circulation. 2016. PMID: 27881561. doi:10.1161/CIRCULATIONAHA.116.022359

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。